BRCA2 germline mutations in Swedish breast cancer families

被引:20
|
作者
Chen, JD
Hedman, MZ
Arver, BW
Sigurdsson, S
Eyfjörd, JE
Lindblom, A [1 ]
机构
[1] Karolinska Inst, S-17176 Stockholm, Sweden
[2] Iceland Canc Soc, Mol & Cell Biol Res Lab, Reykjavik, Iceland
关键词
hereditary breast cancer; breast cancer susceptibility gene; BRCA2; cancer family; gene mutation; familial breast cancer; mutations screening;
D O I
10.1038/sj.ejhg.5200167
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutations in the breast cancer susceptibility gene (BRCA2) are believed to be responsible for a significant fraction of hereditary breast cancer. To determine the BRCA2 mutation spectrum in a subset of Swedish breast cancer families, 162 families were screened for germline mutations in this gene. A combination of RT-PCR, PTT and direct DNA sequencing was used. Two mutations and one previously reported polymorphic variant resulting in a truncated protein were identified. Our data suggest that only a small proportion of Swedish breast cancer families is attributable to BRCA2 germline mutations. This result, in combination with the low frequency of BRCA1 germline mutations identified in our previous study, suggests additional high penetrant as well as low penetrant breast cancer susceptibility genes are involved in familial breast cancer.
引用
收藏
页码:134 / 139
页数:6
相关论文
共 50 条
  • [21] Identification of a founder BRCA2 mutation in Sardinian breast cancer families
    Monne, Maria
    Piras, Giovanna
    Fancello, Patrizia
    Santona, Maria Cristina
    Uras, Antonella
    Landriscina, Gennaro
    Mastio, Giuseppe
    Gabbas, Attilio
    FAMILIAL CANCER, 2007, 6 (01) : 73 - 79
  • [22] Etiology of familial breast cancer with undetected BRCA1 and BRCA2 mutations: clinical implications
    Eugenia Yiannakopoulou
    Cellular Oncology, 2014, 37 : 1 - 8
  • [23] Identification of a founder BRCA2 mutation in Sardinian breast cancer families
    Maria Monne
    Giovanna Piras
    Patrizia Fancello
    Maria Cristina Santona
    Antonella Uras
    Gennaro Landriscina
    Giuseppe Mastio
    Attilio Gabbas
    Familial Cancer, 2007, 6 : 73 - 79
  • [24] Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India
    Suresh Hedau
    Neeraj Jain
    Syed A. Husain
    Ashish K. Mandal
    Gibanananda Ray
    M. Shahid
    Ravi Kant
    Vishal Gupta
    Nootan K. Shukla
    Suryanarayan S. V. Deo
    Bhudev C. Das
    Breast Cancer Research and Treatment, 2004, 88 : 177 - 186
  • [25] Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2
    Petrucelli, Nancie
    Daly, Mary B.
    Feldman, Gerald L.
    GENETICS IN MEDICINE, 2010, 12 (05) : 245 - 259
  • [26] BRCA2 hereditary breast cancer pathophenotype
    Marcus, JN
    Watson, P
    Page, DL
    Narod, SA
    Tonin, P
    Lenoir, GM
    Serova, O
    Lynch, HT
    BREAST CANCER RESEARCH AND TREATMENT, 1997, 44 (03) : 275 - 277
  • [27] Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India
    Hedau, S
    Jain, N
    Husain, SA
    Mandal, AK
    Ray, G
    Shahid, M
    Kant, R
    Gupta, V
    Shukla, NK
    Deo, SSV
    Das, BC
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 (02) : 177 - 186
  • [28] Brca2 hereditary breast cancer pathophenotype
    Joseph N. Marcus
    Patrice Watson
    David L. Page
    Steven A. Narod
    Patricia Tonin
    Gilbert M. Lenoir
    Olga Serova
    Henry T. Lynch
    Breast Cancer Research and Treatment, 1997, 44 : 275 - 277
  • [29] Identification of Germline BRCA1 Mutations among Breast Cancer Families in Northeastern Iran
    Kooshyar, Mohammad Mahdi
    Nassiri, Mohammadreza
    Mahdavi, Morteza
    Doosti, Mohammad
    Parizadeh, Amirreza
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (07) : 4339 - 4345
  • [30] Association of polymorphisms with a family history of cancer and the presence of germline mutations in the BRCA1/BRCA2 genes
    Gabriela C. Fernandes
    Rodrigo A. D. Michelli
    Cristovam Scapulatempo-Neto
    Edenir I. Palmero
    Hereditary Cancer in Clinical Practice, 14